Lombard Odier Asset Management (Usa) Corp Gilead Sciences, Inc. Transaction History
Lombard Odier Asset Management (Usa) Corp
- $1.32 Billion
- Q2 2024
A detailed history of Lombard Odier Asset Management (Usa) Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lombard Odier Asset Management (Usa) Corp holds 280,000 shares of GILD stock, worth $23.5 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
280,000
Previous 20,549
1262.6%
Holding current value
$23.5 Million
Previous $1.51 Million
1176.41%
% of portfolio
1.45%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.66 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.39 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.07 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.97 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...